Moberg Pharma AB (publ)
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2019-07-01 | Moberg Pharma AB (publ) | Torbjörn Wärnheim | SVP R&D | Acquisition | 7 500 | 42,97 | SEK | 322 275 | 2019-06-27 |
| 2019-07-02 | Moberg Pharma AB (publ) | Anna Helena Constance Ljung | VD | Subscription | 40 000 | 42,97 | SEK | 1 718 800 | 2019-06-27 |
| 2019-07-02 | Moberg Pharma AB (publ) | Anna Helena Constance Ljung | VD | Disposal | 40 000 | 66,672 | SEK | 2 666 888 | 2019-06-27 |
| 2019-07-02 | Moberg Pharma AB (publ) | Peter Wolpert | Styrelseledamot/suppleant | Subscription | 75 000 | 42,97 | SEK | 3 222 750 | 2019-06-27 |
| 2019-07-02 | Moberg Pharma AB (publ) | Peter Wolpert | Styrelseledamot/suppleant | Disposal | 75 000 | 66,672 | SEK | 5 000 415 | 2019-06-27 |
| 2019-07-02 | Moberg Pharma AB (publ) | Peter Wolpert | Styrelseledamot/suppleant | Subscription | 32 620 | 59,5 | SEK | 1 940 890 | 2019-06-27 |
| 2019-07-02 | Moberg Pharma AB (publ) | Peter Wolpert | Styrelseledamot/suppleant | Disposal | 32 620 | 66,672 | SEK | 2 174 847,164 | 2019-06-27 |
| 2019-11-22 | Moberg Pharma AB (publ) | Anna Helena Constance Ljung | VD | Exercise decrease | 13 994 | 46,5 | SEK | 650 721 | 2019-11-21 |
| 2019-11-22 | Moberg Pharma AB (publ) | Malin Nilsson | Office Manager & Executive Assistant | Exercise decrease | 2 557 | 46,5 | SEK | 118 900,5 | 2019-11-21 |
| 2019-11-22 | Moberg Pharma AB (publ) | Mattias Klintemar | Styrelseledamot/suppleant | Exercise decrease | 7 000 | 46,5 | SEK | 325 500 | 2019-11-21 |
| 2019-11-22 | Moberg Pharma AB (publ) | Mark Beveridge | Ekonomi/finanschef | Exercise decrease | 17 064 | 46,5 | SEK | 793 476 | 2019-11-21 |
| 2019-11-22 | Moberg Pharma AB (publ) | Peter Wolpert | Styrelseledamot/suppleant | Exercise decrease | 435 399 | 46,5 | SEK | 20 246 053,5 | 2019-11-21 |
| 2019-11-23 | Moberg Pharma AB (publ) | Annika Christine Magnusson | Senior Director Regulatory Affairs | Exercise decrease | 4 030 | 46,5 | SEK | 187 395 | 2019-11-21 |
| 2019-11-24 | Moberg Pharma AB (publ) | Torbjörn Wärnheim | SVP R&D | Exercise decrease | 6 635 | 46,5 | SEK | 308 527,5 | 2019-11-21 |
| 2019-12-12 | Moberg Pharma AB (publ) | Mark Beveridge | Ekonomi/finanschef | Disposal | 2 064 | 21,95 | SEK | 45 304,8 | 2019-12-08 |
| 2019-12-12 | Moberg Pharma AB (publ) | Mark Beveridge | Ekonomi/finanschef | Disposal | 5 000 | 21,7 | SEK | 108 500 | 2019-12-08 |
| 2019-12-13 | Moberg Pharma AB (publ) | Mark Beveridge | Ekonomi/finanschef | Acquisition | 16 500 | 15,68 | SEK | 258 720 | 2019-12-12 |
| 2020-12-08 | Moberg Pharma AB (publ) | Peter Wolpert | Chairman of the Board of Directors | Disposal | 598 992 | 0 | SEK | 0 | 2020-12-02 |
| 2020-12-22 | Moberg Pharma AB (publ) | Anna Helena Constance Ljung | Chief Executive Officer (CEO)/Managing Directory | Subscription | 16 326 | 6,47 | SEK | 105 629,22 | 2020-12-21 |
| 2020-12-22 | Moberg Pharma AB (publ) | Mattias Klintemar | Member of the Board of Directors | Acquisition | 8 000 | 6,47 | SEK | 51 760 | 2020-12-20 |